Why the hell don't people use punctuation or capitalize anymore? Are you really that lazy or are you that stupid?Nothing wrong with a short term gig and moving on long careers with one company are over for this industry!!!
$5mm by YE is a slam dunk. Net price of $75 vial, 1,000 target hospitals/ASCs only need to use it in 60-70 procedures each. With all the backlogged elective surgeries and a motivated sales force, the timing is perfect for us.stock is way down. Lower than iPo a few months ago. SEctor is up.
What sales? What niche? What u smokin!
Street wants 3-5 million by end of year . 300-500k In actual sales to hospitals is even unlikely.
stock is way down. Lower than iPo a few months ago. SEctor is up.
What sales? What niche? What u smokin!
Street wants 3-5 million by end of year . 300-500k In actual sales to hospitals is even unlikely.
GG said they would!please explain why pharmacy would pay $75 when they can pay 1$ a dose for 4 doses to get 24 hr coverage.. its not the efficacy or the side effect profile. Why would the doctor fight for this. Seriously
"Brando has electrolytes"... What are you talking about??because Brando has electrolytes! Da.
In 2019 Cumberland pharma sold 6 million $ of iv caldolor which is also as you know an iv nsaid
That’s 6 million dollars in its tenth year on the market. The company forecasted 600 million by year ten.
But they don’t have electrolytes! Brando has electrolytes so you’re good.
OK whatever you say. Hoping investors see this right? I gotcha.$5mm by YE is a slam dunk. Net price of $75 vial, 1,000 target hospitals/ASCs only need to use it in 60-70 procedures each. With all the backlogged elective surgeries and a motivated sales force, the timing is perfect for us.
What about the reimbursement to ASC's? Isn't that a big advantage?to the slam dunk person. WHAt is the reason to buy your over priced nsaid. At best 9 out of 10 formulary reviews will be a no. That’s the slam dunk. So far not one person has posted a clear reason and or advantage to this product. If a dose was $10 I could see it not but $75. What is the real or how about this your perceived clinical or economic or at least patient satisfaction benefit over toradol thst could justify an over a
1500 percent price increase over toradol.
That’s what pharmacy will Asking at every review. Qd is not gonna cut it and either is the yet to be identified mystery niche patient.
Hello?
Non-opioid, QD dosing and duration of affect, is going to allow end of procedure dosing and earlier discharge without the breakthrough pain and middle of the night calls and AEs. Plus the reimbursement in ASCs is favorable. Getting the surgeon and Anesthesiologist experience in the ASC should allow for cross over penetration into the institution. Slam dunkWhat about the reimbursement to ASC's? Isn't that a big advantage?
My 24 hour non-opioid is going to kick your 6hr IV NSAID's ass.Stop with the ‘non-opioid’ buzz word. You’re an IV NSAID.
My 24 hour non-opioid is going to kick your 6hr IV NSAID's ass.
Be afraid.
Be very afraid
ASC's I can maybe see but good luck with the Institutions. Surgeons and Anesthesiologists don't decide what's on formulary in the hospital systems, the pharmacists do and unless you have data showing amazing efficacy vs toradol you won't move business there. Period. Come on... you've got to know that.Non-opioid, QD dosing and duration of affect, is going to allow end of procedure dosing and earlier discharge without the breakthrough pain and middle of the night calls and AEs. Plus the reimbursement in ASCs is favorable. Getting the surgeon and Anesthesiologist experience in the ASC should allow for cross over penetration into the institution. Slam dunk
